Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › EPAC1 inhibitors for the treatment of idiopathic pulmonary fibrosis

EPAC1 inhibitors for the treatment of idiopathic pulmonary fibrosis

US Patent 12502382 · Granted Dec 23, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tetrahydroquinoline derivatives and their use as Epac inhibitors2018
Tetrahydroquinoline derivatives and their use as Epac inhibitors2018
Tetrahydroquinoline derivatives and their use as Epac inhibitors2017
Tetrahydroquinoline derivatives and their use as Epac inhibitors2017
Aryl carbamate derivatives, preparation and use thereof2007